Cite

    Nakazawa, M. et al. (n.d.). Lower levels of high-density lipoprotein cholesterol are associated with increased cardiovascular events in patients with acute coronary syndrome receiving contemporary lipid-lowering therapy. European heart journal. p. . [Online].